Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis c patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Autor(es) y otros:
Fecha de publicación:
2023
Descripción física:
p. S1205-S1206
Descripción:
European Association for the Study of the Liver, EASL, Congress (2023. Vienna, Austria)